Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Support regulatory review activities related to site activation across clinical studies. Manage Regulatory Affairs contracts and invoices; maintain and update internal RA tracking tools. Archive regulatory documents in accordance with internal procedures and maintain the regulatory query tracker. Support regulatory submission workflows in Veeva. Co-host Regulatory Sub-Team meetings, including agenda preparation and documentation of action items. Participate in RAxROxMW workshops and Regulatory Strategy Forums. Conduct weekly one-on-one meetings with the RA Manager to review priorities and progress. Build and maintain working knowledge of FDA regulations, guidances, and applicable regulatory requirements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern
Number of Employees
251-500 employees